Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDK | P21741 | 4/20 | 0.53 |
| ▸ | BDNF | P23560 | 3/20 | 0.53 |
| ▸ | PTN | P21246 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 4/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.43 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.43 |
| ▸ | F10 | P00742 | 2/20 | 0.40 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.38 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.38 |
| ▸ | CCL2 | P13500 | 1/20 | 0.38 |
| ▸ | CCL5 | P13501 | 1/20 | 0.38 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.38 |
| ▸ | CD69 | Q07108 | 1/20 | 0.37 |
| ▸ | FGF2 | P09038 | 2/20 | 0.36 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29535260 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL5790851 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL18079769 | 1.00 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL13321878 | 0.94 | MDK (0.61) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL29371806 | 0.94 | MDK (0.61) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL29501172 | 0.94 | BDNF (0.49) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL29523446 | 0.94 | BDNF (0.49) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL23336378 | 0.91 | MDK (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL23135897 | 0.89 | BDNF (0.53) | MDKBDNFPTNMAPK1LGALS3 | |
| SCHEMBL29362404 | 0.89 | MDK (0.44) | MDKBDNFPTNMAPK1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080254-A | Chondroitin sulfate A oligosaccharide and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-114853920-A | Giant salamander cartilage chondroitin sulfate and extraction method thereof | 清华大学 | 2022-08-05 | — | — | CN | claimed |
| CN-113403296-B | Recombinant chondrosulphatase AC and preparation method and application thereof | 江苏大学 | 2022-06-21 | — | — | CN | claimed |
| US-20250161362-A1 | Combined preparation for its use in the improvement of the muscle health | BIOIBERICA, S.A.U. (ES) | 2025-05-22 | — | — | US | disclosed |
| EP-4013466-B1 | METHOD FOR IN VITRO PRODUCTION OF HYALINE CARTILAGE TISSUE | VANARIX SA (CH) | 2024-10-16 | — | — | EP | disclosed |
| CN-118459569-A | VAR2CSA recombinant protein and preparation method and application thereof | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 2024-08-09 | — | — | CN | disclosed |
| CN-116874578-B | VAR2CSA recombinant protein and preparation method and application thereof | 中山大学肿瘤防治中心(中山大学附属肿瘤医院 中山大学肿瘤研究所) | 2024-07-19 | — | — | CN | disclosed |
| US-20240052012-A1 | PLATELET ALPHA-GRANULES FOR DELIVERY OF MULTIPLE PROTEINS | LONGITUDE THERAPEUTICS S.R.L. (IT) | 2024-02-15 | — | — | US | disclosed |
| CN-114470337-B | Powder compositions for producing cross-linked protein foam and methods of use thereof | 百奥诚智有限公司 | 2023-12-19 | — | — | CN | disclosed |
| EP-4284917-A2 | PLATELET ALPHA-GRANULES FOR DELIVERY OF MULTIPLE PROTEINS | CSTS Health Care Inc. (CA) | 2023-12-06 | — | — | EP | disclosed |
| CN-116874578-A | VAR2CSA recombinant protein and preparation method and application thereof | 中山大学肿瘤防治中心(中山大学附属肿瘤医院 中山大学肿瘤研究所) | 2023-10-13 | — | — | CN | disclosed |
| CN-109562098-B | PLA2 inhibitors for immediate treatment of hymenoptera toxicity and other conditions due to histamine release | 奥菲瑞克斯股份有限公司 | 2023-04-21 | — | — | CN | disclosed |
| US-20230079832-A1 | NON-INVASIVE PH-DEPENDENT IMAGING USING QUANTITATIVE CHEMICAL EXCHANGE SATURATION TRANSFER (QCEST) | CEDARS-SINAI MEDICAL CENTER (US) | 2023-03-16 | — | — | US | disclosed |
| EP-3442503-B1 | INJECTABLE COMPOSITION FOR DELIVERY OF A BIOLOGICALLY ACTIVE AGENT | CAPSULAR TECH PTY LTD (AU) | 2023-03-15 | — | — | EP | disclosed |
| US-11547348-B2 | Non-invasive pH-dependent imaging using quantitative chemical exchange saturation transfer (qCEST) | CEDARS-SINAI MEDICAL CENTER (US) | 2023-01-10 | — | — | US | disclosed |
| US-20220315897-A1 | METHOD FOR IN VITRO PRODUCTION OF HYALINE CARTILAGE TISSUE | VANARIX SA (CH) | 2022-10-06 | — | — | US | disclosed |
| CN-114853920-A | Giant salamander cartilage chondroitin sulfate and extraction method thereof | 清华大学 | 2022-08-05 | — | — | CN | disclosed |
| WO-2022165043-A2 | PLATELET ALPHA-GRANULES FOR DELIVERY OF MULTIPLE PROTEINS | CSTS HEALTH CARE INC. (CA) | 2022-08-04 | — | — | WO | disclosed |
| EP-4013466-A1 | METHOD FOR IN VITRO PRODUCTION OF HYALINE CARTILAGE TISSUE | Vanarix SA (CH) | 2022-06-22 | — | — | EP | disclosed |
| US-20220135651-A1 | A MEMBRANE-BOUND FIT-1 DECOY AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-05-05 | — | — | US | disclosed |